AMS
American Shared Hospital Services
AMS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over AMS overall, supported by lower modeled downside and stronger modeled upside.
AMS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Weak |
AMS's revenue and cash flow are currently healthy, but its profitability and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AMS PE Valuation
AMS has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AMS Forward outlook
There aren't enough analyst estimates for AMS to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AMS Earnings Per Share
AMS and UNH do not have enough comparable growth data to identify a winner.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
AMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.4M | +19% |
| Q1 2026 | $7.1M | +16% |
| Q4 2025 | $7.7M | -15% |
| Q3 2025 | $7.2M | +2.5% |
| Q2 2025 | $7.1M | +0.2% |
| Q1 2025 | $6.1M | +17% |
| Q4 2024 | $9.1M | +59% |
| Q3 2024 | $7M | +36% |
AMS has the edge over UNH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -11% | -3.1 points |
| Q1 2026 | -13% | +8.2 points |
| Q4 2025 | -18% | +2.1 points |
| Q3 2025 | -4.8% | +7.9 points |
| Q2 2025 | -7.7% | -7.7 points |
| Q1 2025 | -21% | -20 points |
| Q4 2024 | -20% | -27 points |
| Q3 2024 | -13% | -14 points |
AMS's operating margin was −11% last quarter, down 3.1 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over AMS on profitability, with a higher operating margin.
AMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.2M | +$4.5M |
| Q1 2026 | $2.1M | +$3.6M |
| Q4 2025 | $1.3M | +$5.7M |
| Q3 2025 | -$2M | -$1.6M |
| Q2 2025 | -$2.3M | -3347% |
| Q1 2025 | -$1.5M | +$1.5M |
| Q4 2024 | -$4.4M | -$1.2M |
| Q3 2024 | -$407K | -$356K |
AMS's free cash flow has turned positive after two years mostly in the red: $4M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AMS on cash flow, with more consistent year-over-year improvement.
AMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +147K shares |
| 1 year | +4.4% | +290K shares |
| 3 years | +8.5% | +536K shares |
| 5 years | +18% | +1.1M shares |
| Available history | +16% | +964K shares |
AMS has 7M diluted shares, up 4.4% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.3x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 6.5x | High |
| Q3 2025 | 6.3x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 2.7x | Moderate |
| Q3 2024 | 0.1x | Very low |
AMS's net debt is about 5.3 years of its operating earnings (EBITDA), up from 4.7 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over AMS on leverage, with a lower net debt burden relative to earnings.
AMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.1 | Neutral |
| Stochastic | 11.8 | Oversold |
AMS's weekly RSI is 30 (neutral) and its Stochastic is 12 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AMS PE vs Healthcare Sector
| Metric | AMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
AMS has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.28 | 15% below |
| 20 week MA | $1.39 | 22% below |
| 50 week MA | $1.66 | 34% below |
| 100 week MA | $2.15 | 49% below |
| 200 week MA | $2.51 | 57% below |
AMS is in a downtrend: it's below all five of its weekly moving averages, and 57% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over AMS on trend strength, trading above more of its moving averages.
AMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.56 | $2.10 | -18% |
| 2021 | $2.10 | $2.42 | +15% |
| 2022 | $2.42 | $2.81 | +16% |
| 2023 | $2.81 | $2.38 | -15% |
| 2024 | $2.38 | $3.19 | +34% |
| 2025 | $3.19 | $2.14 | -33% |
| 2026 YTD | $2.14 | $1.09 | -49% |
AMS has finished lower in three of the last six years. It's down 49% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over AMS on returns for 2026, with the stronger performance.